SpringWorks Therapeutics Inc (SWTX)
30.92
+0.30
(+0.98%)
USD |
NASDAQ |
Nov 04, 16:00
30.15
-0.77
(-2.49%)
After-Hours: 07:47
SpringWorks Therapeutics Max Drawdown (5Y): 80.38% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 80.38% |
| September 30, 2024 | 80.38% |
| August 31, 2024 | 80.38% |
| July 31, 2024 | 80.38% |
| June 30, 2024 | 80.38% |
| May 31, 2024 | 80.38% |
| April 30, 2024 | 80.38% |
| March 31, 2024 | 80.38% |
| February 29, 2024 | 80.38% |
| January 31, 2024 | 80.38% |
| December 31, 2023 | 80.38% |
| November 30, 2023 | 80.38% |
| October 31, 2023 | 80.38% |
| September 30, 2023 | 80.38% |
| August 31, 2023 | 80.38% |
| July 31, 2023 | 80.38% |
| June 30, 2023 | 80.38% |
| May 31, 2023 | 80.38% |
| April 30, 2023 | 80.38% |
| March 31, 2023 | 80.38% |
| February 28, 2023 | 80.38% |
| January 31, 2023 | 80.38% |
| December 31, 2022 | 80.38% |
| November 30, 2022 | 80.38% |
| October 31, 2022 | 80.38% |
| Date | Value |
|---|---|
| September 30, 2022 | 80.38% |
| August 31, 2022 | 80.38% |
| July 31, 2022 | 80.38% |
| June 30, 2022 | 80.38% |
| May 31, 2022 | 80.38% |
| April 30, 2022 | 54.15% |
| March 31, 2022 | 50.40% |
| February 28, 2022 | 50.40% |
| January 31, 2022 | 50.40% |
| December 31, 2021 | 50.40% |
| November 30, 2021 | 50.40% |
| October 31, 2021 | 50.40% |
| September 30, 2021 | 50.40% |
| August 31, 2021 | 50.40% |
| July 31, 2021 | 50.40% |
| June 30, 2021 | 50.40% |
| May 31, 2021 | 50.40% |
| April 30, 2021 | 50.40% |
| March 31, 2021 | 50.40% |
| February 28, 2021 | 50.40% |
| January 31, 2021 | 50.40% |
| December 31, 2020 | 50.40% |
| November 30, 2020 | 50.40% |
| October 31, 2020 | 50.40% |
| September 30, 2020 | 50.40% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
36.23%
Minimum
Nov 2019
80.38%
Maximum
May 2022
64.51%
Average
67.27%
Median
Max Drawdown (5Y) Benchmarks
| Ocugen Inc | 99.95% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |